Google DeepMind released AlphaGenome Atlas, a 1 PB database that precomputes AI predictions for all 9 billion possible single-nucleotide variants (SNVs) in human DNA and their health impacts. The tool uses the AlphaGenome model to assess how specific mutations affect the body, accessible via web interface or API. This addresses a long-standing research bottleneck—lab validation of mutation effects was previously impractical at scale. Early adoption by life science research units signals real-world utility for genomics research and drug development workflows.